CRISPR Therapeutics AG - CRSP
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Chief Financial Officer | G | D | 750.0 | 0.0 | 0.0 | 14,815.0 | View | |
| Jun 09, 2026 | — | A | A | 13,000.0 | 0.0 | 0.0 | 13,000.0 | View | |
| Jun 09, 2026 | — | A | A | 13,000.0 | 0.0 | 0.0 | 13,000.0 | View | |
| Jun 09, 2026 | — | A | A | 13,000.0 | 0.0 | 0.0 | 13,000.0 | View | |
| Jun 09, 2026 | — | A | A | 13,000.0 | 0.0 | 0.0 | 13,000.0 | View | |
| Jun 09, 2026 | — | A | A | 13,000.0 | 0.0 | 0.0 | 13,000.0 | View | |
| Jun 09, 2026 | — | A | A | 13,000.0 | 0.0 | 0.0 | 13,000.0 | View | |
| Jun 09, 2026 | — | A | A | 13,000.0 | 0.0 | 0.0 | 13,000.0 | View | |
| Jun 09, 2026 | — | A | A | 13,000.0 | 0.0 | 0.0 | 13,000.0 | View | |
| Jun 09, 2026 | — | A | A | 13,000.0 | 0.0 | 0.0 | 13,000.0 | View | |
| Jun 09, 2026 | — | A | A | 13,000.0 | 0.0 | 0.0 | 13,000.0 | View | |
| Jun 02, 2026 | General Counsel and Secretary | A | A | 17,000.0 | 0.0 | 0.0 | 17,000.0 | View | |
| Jun 02, 2026 | Chief Medical Officer | A | A | 22,000.0 | 0.0 | 0.0 | 22,000.0 | View | |
| Jun 02, 2026 | Chief Financial Officer | A | A | 19,500.0 | 0.0 | 0.0 | 19,500.0 | View | |
| Jun 01, 2026 | Chief Medical Officer | M | D | 10,000.0 | — | — | 20,000.0 | View | |
| Jun 01, 2026 | Chief Medical Officer | S | D | 3,786.0 | 55.62 | 210,577.32 | 19,357.0 | View | |
| Jun 01, 2026 | Chief Medical Officer | M | A | 10,000.0 | — | — | 23,143.0 | View |